NCT04780815View on ClinicalTrials.gov

An Exploratory PET-study of Deposition, Disposition and Brain Uptake of [11C]Nicotine After Inhalation of 2 Nicotine Formulations Via the myBluTM E-cigarette in Smokers

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 16, 2020

Primary Completion Date

November 17, 2020

Study Completion Date

November 17, 2020

Conditions
Healthy Volunteers
Interventions
OTHER

myBluTM Formulation 1

1-2 puffs of each 3-5 seconds duration taken from myBluTM with Formulation 1, with inhalation of the vapour into the lungs

OTHER

myBluTM Formulation 2

1-2 puffs of each 3-5 seconds duration taken from myBluTM with Formulation 2, with inhalation of the vapour into the lungs

Trial Locations (1)

SE-751 85

PET Centre, Uppsala University Hospital, Uppsala

All Listed Sponsors
collaborator

Nerudia Ltd

INDUSTRY

lead

Imperial Brands PLC

INDUSTRY

NCT04780815 - An Exploratory PET-study of Deposition, Disposition and Brain Uptake of [11C]Nicotine After Inhalation of 2 Nicotine Formulations Via the myBluTM E-cigarette in Smokers | Biotech Hunter | Biotech Hunter